Back to top
Erlot 150 mg Tablet
Erlot 150 mg Tablet

Erlot 150 mg Tablet

Erlot 150 mg Tablet Specification

  • Pacakaging (Quantity Per Box)
  • 10 strips per box
  • Salt Composition
  • Erlotinib Hydrochloride
  • Origin of Medicine
  • Synthetic
  • Drug Type
  • Anticancer
  • Ingredients
  • Erlotinib Hydrochloride
  • Physical Form
  • Tablet
  • Function
  • Used to treat non-small cell lung cancer and pancreatic cancer
  • Recommended For
  • Patients with non-small cell lung cancer or pancreatic cancer
  • Dosage
  • 150 mg
  • Dosage Guidelines
  • Take one tablet orally once a day on an empty stomach or as directed by a physician
  • Suitable For
  • Adults
  • Quantity
  • 10 tablets per strip
  • Storage Instructions
  • Store in a cool dry place below 30C and protect from light and moisture
 
 

About Erlot 150 mg Tablet



Erlot 150 mg Tablet is an anticancer medication containing Erlotinib Hydrochloride. It is recommended for adults with non-small cell lung cancer or pancreatic cancer. The dosage is 150 mg to be taken orally once daily on an empty stomach or as directed by a physician. These tablets are specifically designed to treat non-small cell lung cancer and pancreatic cancer. Each box contains 10 strips, with 10 tablets per strip, making it convenient for a complete treatment course. The tablets should be stored in a cool, dry place below 30C, protected from light and moisture.

FAQs of Erlot 150 mg Tablet:


Q: What is the recommended dosage of Erlot 150 mg Tablet?

A: The recommended dosage of Erlot 150 mg Tablet is 150 mg to be taken orally once daily on an empty stomach or as directed by a physician.

Q: Who is Erlot 150 mg Tablet suitable for?

A: Erlot 150 mg Tablet is suitable for adults with non-small cell lung cancer or pancreatic cancer.

Q: What is the function of Erlot 150 mg Tablet?

A: Erlot 150 mg Tablet is used to treat non-small cell lung cancer and pancreatic cancer.

Q: How should Erlot 150 mg Tablet be stored?

A: Erlot 150 mg Tablet should be stored in a cool, dry place below 30C, protected from light and moisture.

Q: What is the composition of Erlot 150 mg Tablet?

A: Erlot 150 mg Tablet contains Erlotinib Hydrochloride as its main salt composition.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Xovoltib 50 mg Tablet

Xovoltib 50 mg Tablet

Ingredients : Afatinib (50 mg)

Storage Instructions : Store in a cool dry place below 30C away from direct sunlight and moisture

Quantity : Pack of 10 tablets

Origin of Medicine : Allopathic

Recommended For : Patients with specific types of advanced nonsmall cell lung cancer (NSCLC) that have EGFR mutations

Dosage Guidelines : Take the tablet on an empty stomach at least 1 hour before or 2 hours after eating

Nufil safe 300 mcg Injection

Nufil safe 300 mcg Injection

Ingredients : Filgrastim

Storage Instructions : Store in a refrigerator between 2C to 8C. Do not freeze.

Quantity : 1 vial

Origin of Medicine : Biotechnologyderived

Recommended For : Patients undergoing chemotherapy bone marrow transplantation or those with neutropenia.

Dosage Guidelines : Administered under the supervision of a healthcare professional. Usage frequency and duration are based on medical advice.

Innocar 450 mg Injection

Innocar 450 mg Injection

Ingredients : Inositol Nicotinate

Storage Instructions : Store in a cool and dry place away from direct sunlight

Quantity : 1 vial

Origin of Medicine : Allopathic

Recommended For : Patients with circulatory problems

Dosage Guidelines : To be administered under the supervision of a healthcare professional

Cytarabine 1000 mg Injection

Cytarabine 1000 mg Injection

Ingredients : Cytarabine 1000 mg

Storage Instructions : Store in a refrigerator (2C to 8C). Do not freeze. Protect from light

Quantity : One vial per unit

Origin of Medicine : Synthetic

Recommended For : Cancer patients undergoing chemotherapy

Dosage Guidelines : Administered under the supervision of a qualified healthcare professional typically through intravenous or subcutaneous injection